Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2015

View Archived Issues

DiamiR receives funding to evaluate microRNA biomarkers for Alzheimer's disease

Sirtex reports preliminary data from the SIRFLOX study

Targazyme and M.D. Anderson Cancer Center to conduct study of TZ-101-treated T Cells

AstraZeneca reports phase III topline results for PT-003

FDA orphan drug designations for two IPF drugs

Universitaet zu Koeln divulges anti-CD30 CAR T cells

Non-toxic mitochondrial protonophore formulation shows potential for T2D and NAFLD/NASH

ALN-TTRSC has clinical activity in TTR cardiac amyloidosis patients

Full results presented from phase III ANNEXA-R study of andexanet alfa

BR-297: a neuroprotective allopregnanolone analogue

Targeting amyloid binding alcohol dehydrogenase with frentizole derivatives

Ignyta acquires four oncology R&D assets from Teva Pharmaceutical

Yisheng Biopharma confirms new vaccine for rabies infection will enter human trials

Scioderm begins phase III trial of Zorblisa in patients with epidermolysis bullosa

Janssen acquires XO1

Can-Fite completes development of biomarker blood test for company's drugs

Heron Therapeutics reports data from phase I study of HTX-011

Amicus Therapeutics reports on meetings with EMA and FDA over migalastat

FDA awards orphan drug designation to Selten's SPI-026 for PAH

Actelion presents new antimalarials

University of Utah describes KDM1A inhibitors

Piramal develops FFAR1 agonists

Purdue Pharma presents new sodium Nav1.7 channel blockers

Evotec and Sanofi establish major strategic alliance

Anthera receives Cystic Fibrosis Foundation Therapeutics award to develop Sollpura

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...